BEAM

20.8900.24%
MC

Mark C. Fishman

Independent Lead Director

Dr. Mark C. Fishman, M.D., serves as Chair of Scientific Advisory Board of Tempero Bio. He serves as Director at Ancora Bio Inc. He is a Co-Founder & Chairman of the Scientific Advisory Board at Aditum Bio Management Company, LLC. He serves as Independent Lead Director at Beam Therapeutics Inc since 2024. He serves as Non-Executive Director at Versanis Bio, Inc. Dr. Fishman was a Member of Scientific Advisory Board of Tenaya Therapeutics, Inc. until 2023. He is a Professor of Department of Stem Cell and Regenerative Biology at Harvard and Chief of Pathways Clinical Service at Massachusetts General Hospital. He has been Independent Director at Beam Therapeutics Inc. since May 2018. Dr. Fishman served as the Founding President of Novartis Institutes for BioMedical Research, Inc. since 2002 until March 1, 2016 and served as its Global Head of The Novartis Institute for BioMedical Research (NIBR). He served as the Divisional Head of BioMedical Research of Novartis AG since 2002. Dr. Fishman served as a Consultant in Medicine at the MGH. He served as the President of BioMedical Research of Novartis Consumer Health, Inc. He serves as Director at Teres Bio, Inc. Dr. Fishman has been the Chairman of Semma Therapeutics, Inc. since November 7, 2016. Dr. Fishman served as a Co-Chairman and a Member of Scientific Strategy and Advisory Group of Alnylam Pharmaceuticals Inc. since October 6, 2005. He served as a Professor of Medicine at Harvard Medical School and Chief of Cardiology and founding Director of the Cardiovascular Research Center at the Massachusetts General Hospital. He has been honored with many awards and distinguished lectureships and is a Fellow of the American Academy of Arts and Sciences. He is a Member of the Institute of Medicine of the National Academies, US. He is best known for his studies in developmental genetics, in particular his role in introducing the zebrafish as a model for gene discovery. Dr. Fishman completed his Internal Medicine Residency, Chief Residency and Cardiology training at the Massachusetts General Hospital. Dr. Fishman graduated with a B. A. from Yale College in 1972 and an M. D. from Harvard Medical School in 1976.

Positions